Chargement en cours...
Varenicline, Low Dose naltrexone, and their combination for heavy-drinking smokers: Human laboratory findings
RATIONALE: Heavy drinking smokers constitute a sizeable and hard-to-treat subgroup of smokers, for whom tailored smoking cessation therapies are not yet available. OBJECTIVES: The present study used a double-blind, randomized, 2×2 medication design, testing varenicline alone (VAR; 1mg twice daily),...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4161630/ https://ncbi.nlm.nih.gov/pubmed/24733235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-014-3519-0 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|